Cargando…

Retracted: Metoprolol Mitigates Ischemic Heart Remodeling and Fibrosis by Increasing the Expression of AKAP5 in Ischemic Heart

Detalles Bibliográficos
Autor principal: Longevity, Oxidative Medicine and Cellular
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10551426/
https://www.ncbi.nlm.nih.gov/pubmed/37810553
http://dx.doi.org/10.1155/2023/9897437
_version_ 1785115763461324800
author Longevity, Oxidative Medicine and Cellular
author_facet Longevity, Oxidative Medicine and Cellular
author_sort Longevity, Oxidative Medicine and Cellular
collection PubMed
description
format Online
Article
Text
id pubmed-10551426
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-105514262023-10-06 Retracted: Metoprolol Mitigates Ischemic Heart Remodeling and Fibrosis by Increasing the Expression of AKAP5 in Ischemic Heart Longevity, Oxidative Medicine and Cellular Oxid Med Cell Longev Retraction Hindawi 2023-09-27 /pmc/articles/PMC10551426/ /pubmed/37810553 http://dx.doi.org/10.1155/2023/9897437 Text en Copyright © 2023 Oxidative Medicine and Cellular Longevity. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Retraction
Longevity, Oxidative Medicine and Cellular
Retracted: Metoprolol Mitigates Ischemic Heart Remodeling and Fibrosis by Increasing the Expression of AKAP5 in Ischemic Heart
title Retracted: Metoprolol Mitigates Ischemic Heart Remodeling and Fibrosis by Increasing the Expression of AKAP5 in Ischemic Heart
title_full Retracted: Metoprolol Mitigates Ischemic Heart Remodeling and Fibrosis by Increasing the Expression of AKAP5 in Ischemic Heart
title_fullStr Retracted: Metoprolol Mitigates Ischemic Heart Remodeling and Fibrosis by Increasing the Expression of AKAP5 in Ischemic Heart
title_full_unstemmed Retracted: Metoprolol Mitigates Ischemic Heart Remodeling and Fibrosis by Increasing the Expression of AKAP5 in Ischemic Heart
title_short Retracted: Metoprolol Mitigates Ischemic Heart Remodeling and Fibrosis by Increasing the Expression of AKAP5 in Ischemic Heart
title_sort retracted: metoprolol mitigates ischemic heart remodeling and fibrosis by increasing the expression of akap5 in ischemic heart
topic Retraction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10551426/
https://www.ncbi.nlm.nih.gov/pubmed/37810553
http://dx.doi.org/10.1155/2023/9897437
work_keys_str_mv AT longevityoxidativemedicineandcellular retractedmetoprololmitigatesischemicheartremodelingandfibrosisbyincreasingtheexpressionofakap5inischemicheart